These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1174 related articles for article (PubMed ID: 24477973)

  • 21. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered mitochondrial metabolism in the insulin-resistant heart.
    Makrecka-Kuka M; Liepinsh E; Murray AJ; Lemieux H; Dambrova M; Tepp K; Puurand M; Käämbre T; Han WH; de Goede P; O'Brien KA; Turan B; Tuncay E; Olgar Y; Rolo AP; Palmeira CM; Boardman NT; Wüst RCI; Larsen TS
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13430. PubMed ID: 31840389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic cardiomyopathy.
    Lee MMY; McMurray JJV; Lorenzo-Almorós A; Kristensen SL; Sattar N; Jhund PS; Petrie MC
    Heart; 2019 Feb; 105(4):337-345. PubMed ID: 30337334
    [No Abstract]   [Full Text] [Related]  

  • 24. Diabetes Mellitus and the Heart.
    Schütt K; Müller-Wieland D; Marx N
    Exp Clin Endocrinol Diabetes; 2019 Dec; 127(S 01):S102-S104. PubMed ID: 31860930
    [No Abstract]   [Full Text] [Related]  

  • 25. Alterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation.
    Joshi MS; Mihm MJ; Cook AC; Schanbacher BL; Bauer JA
    J Diabetes; 2015 Mar; 7(2):250-259. PubMed ID: 24796789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.
    An D; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1489-506. PubMed ID: 16751293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy.
    Kubli DA; Gustafsson ÅB
    Antioxid Redox Signal; 2015 Jun; 22(17):1527-44. PubMed ID: 25808102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on diabetic cardiomyopathy: inches forward, miles to go.
    Tillquist MN; Maddox TM
    Curr Diab Rep; 2012 Jun; 12(3):305-13. PubMed ID: 22528596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic cardiomyopathy: pathophysiological mechanisms of structural and functional changes.].
    Slavíková J; Mistrová E; Dvoráková Chottová M
    Cesk Fysiol; 2016 Oct; 65(2):75-83. PubMed ID: 29489085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic cardiomyopathy: a brief summary on lipid toxicity.
    Ke J; Pan J; Lin H; Gu J
    ESC Heart Fail; 2023 Apr; 10(2):776-790. PubMed ID: 36369594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital admissions for cardiovascular complications of people with or without diabetes, Victoria, 2004-2016.
    Kiburg KV; MacIsaac AI; Wilson A; Sundararajan V; MacIsaac RJ
    Med J Aust; 2021 Jul; 215(2):85-86. PubMed ID: 34028039
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats.
    Despa S; Margulies KB; Chen L; Knowlton AA; Havel PJ; Taegtmeyer H; Bers DM; Despa F
    Circ Res; 2012 Feb; 110(4):598-608. PubMed ID: 22275486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus.
    Gonçalves N; Gomes-Ferreira C; Moura C; Roncon-Albuquerque R; Leite-Moreira AF; Falcão-Pires I
    Int J Cardiol; 2016 Aug; 217():195-204. PubMed ID: 27195451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: The Role of Ceramides in Diabetes and Cardiovascular Disease.
    Summers SA
    Front Endocrinol (Lausanne); 2021; 12():667885. PubMed ID: 33776946
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.
    Dei Cas A; Spigoni V; Ridolfi V; Metra M
    Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.
    LaRocca TJ; Fabris F; Chen J; Benhayon D; Zhang S; McCollum L; Schecter AD; Cheung JY; Sobie EA; Hajjar RJ; Lebeche D
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H353-67. PubMed ID: 22610174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updating experimental models of diabetic cardiomyopathy.
    Fuentes-Antrás J; Picatoste B; Gómez-Hernández A; Egido J; Tuñón J; Lorenzo Ó
    J Diabetes Res; 2015; 2015():656795. PubMed ID: 25973429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.